六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioScience(AYTU)$ 425 Prospectuses and communications, business combinations Accession Number: 0001213900-20-041934 Act: 34 Size: 66 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 3.03, 5.03, and 9.01 Accession Number: 0001654954-20-013283 Act: 34 Size: 40 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, item 8.01 Accession Number: 0001654954-20-013129 Act: 34 Size: 25 KB 网页链接
$Aytu BioScience(AYTU)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001654954-20-012265 Act: 34 Size: 4 MB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001654954-20-012254 Act: 34 Size: 289 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001654954-20-010889 Act: 34 Size: 390 KB 网页链接
$Aytu BioScience(AYTU)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001654954-20-010891 Act: 34 Size: 8 MB 网页链接
$Aytu BioScience(AYTU)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001213900-20-028696 Act: 34 Size: 26 KB 网页链接
$Aytu BioScience(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001654954-20-009234 Size: 6 KB 网页链接
$Aytu BioScience(AYTU)$ 8-K Current report, items 1.01, 3.02, 5.02, and 9.01 Accession Number: 0001213900-20-016604 Act: 34 Size: 192 KB 网页链接